THIS DOCUMENT HAS BEEN SIGNED IN COUNTERPART
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(f) under the Securities Exchange Act
of 1934, the persons named below agree to the joint filing on behalf of each of
them of a Statement on Schedule 13G (including amendments thereto) with respect
to the common stock of Viropharma Incorporated, and further agree that this
Joint Filing Agreement be included as an exhibit to such joint filings. In
evidence thereof each of the undersigned, being duly authorized, hereby execute
this Agreement on the date set forth opposite its or his name.
▇▇▇▇▇ ▇▇▇▇▇ FUND IV L.P.
By: SRB Associates IV L.P.,
General Partner
Dated: February 16, 1999 By:/s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
----------------------------------------
▇▇▇▇ ▇. ▇▇▇▇▇▇▇, a General Partner
SRB ASSOCIATES IV L.P.
Dated: February 16, 1999 By: /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇ ▇. ▇▇▇▇▇▇▇, a General Partner
Dated: February 16, 1999 /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇ ▇. ▇▇▇▇▇▇▇, by ▇▇▇▇ ▇. ▇▇▇▇▇▇▇,
Attorney-in-Fact
Dated: February 16, 1999 /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇, by ▇▇▇▇ ▇. ▇▇▇▇▇▇▇,
Attorney-in-Fact
Dated: February 16, 1999 /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇ ▇. ▇▇▇▇▇▇▇
Dated: February 16, 1999 /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇,
by ▇▇▇▇ ▇. ▇▇▇▇▇▇▇, Attorney-in-Fact
Dated: February 16, 1999 /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇,
by ▇▇▇▇ ▇. ▇▇▇▇▇▇▇, Attorney-in-Fact
